Renaissance Capital logo

Denali Capital Acquisition Priced, Nasdaq: DECA

Fourth blank check company formed by the CEO of US Tiger Securities (pending: Longevity Biomedical).

Industry: SPAC

Latest Trade: $9.20 0.00 (0.0%)

First Day Return: +0.2%

Return from IPO: -8.0%

Industry: SPAC

We are a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any specific business combination target, and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. We are focused on identifying unique business concepts with high-performing organizations that have both aspirations to accelerate growth and create enduring value within the technology, hospitality, or consumer services sectors.
more less
IPO Data
IPO File Date 03/01/2022
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 7.5
Deal Size ($mm) $75
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 04/06/2022
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 7.5
Deal Size ($mm) $75
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
Tiger Brokers
EF Hutton
Company Data
Headquarters New York, NY, United States
Founded 2022
Employees 1

Denali Capital Acquisition (DECA) Performance